Printer Friendly

VALLEYLAB INC SETTLES LITIGATION WITH BIRTCHER MEDICAL SYSTEMS, OBTAINS LICENSE FOR ARGON BEAM TECHNOLOGY

 VALLEYLAB INC SETTLES LITIGATION WITH BIRTCHER MEDICAL SYSTEMS,
 OBTAINS LICENSE FOR ARGON BEAM TECHNOLOGY
 NEW YORK, Aug. 25 /PRNewswire/ -- Valleylab Inc, a subsidiary of Pfizer Inc (NYSE: PFE), announced yesterday that it had settled pending litigation with Birtcher Medical Systems and, in that connection, obtained a non-exclusive license to make, use and sell products containing Birtcher's patented technology for gas-enhanced electrosurgery.
 William Reichenberg, president of Valleylab, said, "This settlement enables Valleylab to better satisfy the needs of its customers. As the world leader in advanced surgical technology, we feel that argon-gas coagulation rounds out our product offering."
 Valleylab, headquartered in Boulder, Colo., manufactures and markets a full line of electrosurgical and ultrasonic surgical instrumentation for the health-care industry. Argon-enhanced surgical systems are a small, but growing, part of Valleylab's total worldwide business.
 Pfizer is a research-based, diversified healthcare company, with global operations. It reported sales of approximately 6.9 billion dollars for 1991.
 -0- 8/25/92
 /CONTACT: Rick Honey of Pfizer, 212-573-2051/
 (PFE) CO: Valleylab Inc; Pfizer Inc; Birtcher Medical Systems ST: New York IN: HEA SU: LIC


KD -- NY078 -- 3185 08/25/92 17:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 25, 1992
Words:188
Previous Article:STANDARD & POOR'S STOCK PRICE INDEX -- CLOSING, TUESDAY, AUG. 25 /PRN/
Next Article:TRANSCON INC. REPORTS SECOND QUARTER RESULTS
Topics:


Related Articles
VALLEYLAB FILES DECLARATORY JUDGMENT SUIT AGAINST BIRTCHER MEDICAL SYSTEMS
BIRTCHER MEDICAL SYSTEMS CONFIRMS DISCUSSIONS WITH PFIZER
CONMED CHARGES BIRTCHER WITH PATENT INFRINGEMENT
CONMED NAMES AN ADDITIONAL COMPETITOR TO PATENT SUIT
BIRTCHER MEDICAL NAMES NEW PRESIDENT AND CEO TO LEAD STREAMLINED COMPANY; REPORTS THIRD QUARTER LOSSES
BIRTCHER MEDICAL PROMOTES THREE EXECUTIVES, CONTINUING NEW LEADERSHIP AND COMPANY REFORM
BIRTCHER MEDICAL PROMOTES THREE EXECUTIVES, CONTINUING NEW LEADERSHIP AND COMPANY REFORM
BIRTCHER REPORTS FIRST QUARTER RESULTS
BIRTCHER REPORTS YEAR END RESULTS; COMPANY PLANS $7 MILLION CONVERTIBLE PREFERRED STOCK OFFERING
LENDER CONTINUES BIRTCHER MEDICAL SYSTEMS' CREDIT LINE

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters